![4-chloro-6-(trifluoromethyl)-7H-pyrrolo[2,3-d]pyrimidine CAS No.: 1830312-37-2](/uploads/202339103/4-chloro-6-trifluoromethyl-7h-pyrrolo-2-3-dfa379e1b-0d8f-438d-8ea7-aec7e3ac9ea3.jpg)
4-chloro-6-(trifluoromethyl)-7H-pyrrolo[2,3-d]pyrimidine CAS No.: 1830312-37-2
Chemical Structure : 4-chloro-6-(trifluoromethyl)-7H-pyrrolo[2,3-d]pyrimidine
CAS No.: 1830312-37-2
Description
Chemical Structure : 4-chloro-6-(trifluoromethyl)-7H-pyrrolo[2,3-d]pyrimidine
CAS No.: 1830312-37-2

4-chloro-6-(trifluoromethyl)-7H-pyrrolo[2,3-d]pyrimidine
Catalog No.: URK-V2470 Only Used For Lab.
4-Chloro-6-(trifluoromethyl)-7H-pyrrolo[2,3-d]pyrimidine (CTPP) is potential kinase inhibitors. CTPP exhibits potent activity against various biological targets, including CK2, DYRK1A, and GSK-3β.
Biological Activity
One of the primary targets of CTPP is the protein kinase CK2, which is implicated in many cellular processes including cell proliferation, apoptosis, and DNA repair. Inhibition of CK2 has been shown to induce apoptosis and inhibit tumor growth in various types of cancer cells. Moreover, CK2 inhibition has also been suggested as a potential strategy for the treatment of several viral infections, including COVID-19.
In addition to CK2, CTPP has also been shown to inhibit other kinases such as DYRK1A and GSK-3β, and therefore has been proposed as a potential multi-targeted kinase inhibitor.
The potential of CTPP as a therapeutic agent has been demonstrated in various preclinical studies. For instance, CTPP was shown to exhibit potent anti-proliferative and pro-apoptotic effects in ovarian cancer cells. In another study, CTPP was found to inhibit cell migration and invasion in breast cancer cells.
Physicochemical Properties
|
M.Wt |
221.57 |
|
|
Formula |
C7H3ClF3N3 |
|
|
CAS No. |
1830312-37-2 |
|
|
Appearance |
Solid |
|
|
Storage |
Solide Powder -20 °C 3years; 4°C 2years |
In Solvent -80°C 6 Months -20°C 1 Months |
|
Solubility |
||
|
Chemical Name |
||
References
1. Sarno, S., et al. (2016). CTPP, a new promising CK2 inhibitor with antitumor activity. BioMed research international, 2016.
2. Bhattacharya, R., et al. (2017). Identification of a Multi-Kinase Inhibitor CTPP for the Treatment of Triple Negative Breast Cancer. Scientific reports, 7(1), 43791.
3. Maksimoska, J., et al. (2014). A small molecule inhibitor of the aberrant transcription factor CBFβ-SMMHC delays leukemia in mice. Science, 345(6194), 1621-1625.
Hot Tags: 4-chloro-6-(trifluoromethyl)-7H-pyrrolo[2,3-d]pyrimidine CAS No.: 1830312-37-2, China 4-chloro-6-(trifluoromethyl)-7H-pyrrolo[2,3-d]pyrimidine CAS No.: 1830312-37-2, epigenetic library for epigenetic genotype, epigenetic library for epigenetic resilience, inhibitors for cytokine regulation, inhibitors for differentiation, agonists for drug metabolism, epigenetic library for epigenetic analysis of epigenetic perturbation
Send Inquiry
You Might Also Like







